Raremark gets £3m to enable precision medicine in rare disease

Oct 24, 2018 · uktech.news

Screen shot 2018 10 23 at 14.42.08 898x505

HealthTech company Raremark has raised £3m from investors. The round was led by AlbionVC and Ananda Ventures, with participation from Oltre Venture and from existing major investor the Cass Entrepreneurship Fund.

Julie Walters, CEO and founder of Raremark, commented on the news: "Healthcare is becoming increasingly personalized, and precision medicine is enabling the right treatments to be delivered to the right patients. However, accessing credible and structured, real-w0rld patient data remains one of the most acute challenges facing drug development in rare disease."

Lennart Hergel, partner at Ananda Ventures, explained Raremark’s approach: "Raremark has built a technology platform using content algorithms to boost engagement and advanced data analytics to understand the mechanisms, symptoms and heterogeneity of rare diseases. The resulting high-quality insights will enable companies to develop more effective treatments that are tailored to patients’ profiles."

Read Complete Article

RT @GotoGrow_London: Calling creative scale-ups! 🚨 We have a fantastic opportunity available for companies thinking of expanding to China!…

Our @LondonTap points where you can donate to help homeless Londoners have had an incredible 10,000 separate taps s… https://t.co/CquLwjv78c

#TechX365: Berlin-based digital bank @n26 has raised $300 million in a Series D round, funded by @insightpartners a… https://t.co/0m6Afdv3QJ

Twitter bug revealed private tweets for some Android users for almost five years https://t.co/yLy1CGtrhj by @campuscodi

🙇 Ace. 🙇 @onethirdstories are looking for a Customer Support & Generalist https://t.co/SNea9h9fpq #job